Breaking News

Cytovance Biologics Names Quality VP

January 23, 2013

Lopez to oversee Quality operations

Maria Lopez has been appointed vice president of Quality at Cytovance Biologics. Prior to joining the company, Ms. Lopez served as the site Quality head at Novartis, where she was responsible for all Quality functions at the manufacturing facility and for the continuous improvement of the site. Before Novartis, she served as director of Quality and manager of Quality Assurance at Immucor.
 
"With over 15 years of experience in the biopharm industry, Maria brings a depth of experience in medical device and biologics manufacturing," said Darren Head, president and chief executive officer of Cytovance Biologics. "We are very fortunate to have such a well-seasoned and experienced executive join our team. Maria's knowledge and leadership skills will be tremendous assets to the company."
 
Bill Minshall, Cytovance’s most recent senior vice president of Quality Systems, has assumed a new role as senior vice president of Regulatory Affairs. His focus will be to coordinate, prepare and manage Cytovance and client regulatory submissions to ensure timely approvals.

Related Compliance:

blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision